Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence in inflammatory bowel disease: innovations in diagnosis, monitoring, and personalized care
4
Zitationen
2
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) is redefining the management of inflammatory bowel diseases (IBD) by enhancing diagnostic accuracy, refining disease classification, and optimizing disease monitoring. This review highlights AI's potential to transform IBD management by streamlining clinical workflows, improving diagnostic precision, and supporting personalized treatment strategies. By addressing the limitations of traditional clinical assessments including variability, subjectivity, and resource intensity, AI offers unbiased, consistent, and efficient solutions. Concluding with a forward-looking perspective, this paper emphasizes how integrating AI into clinical practice could lead to more precise, proactive, and patient-centric approaches to IBD care, ultimately enhancing clinical outcomes and quality of life for these patients.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.485 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.371 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.827 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.549 Zit.